Tumor cells elicit metabolic reprogramming to establish an immunosuppressive tumor
microenvironment (TME) for escaping from immunosurveillance. Therefore, interrupting the …

Reactive astrocytes (RA) secrete lipocalin-2 (LCN2) glycoprotein that regulates diverse
cellular processes including cell death/survival, inflammation, iron delivery and cell …

Currently, the controlled release of nitric oxide (NO) plays a crucial role in various
biomedical applications. However, injectable NO-releasing materials remain an …

The novel use of nanofibers as a physical barrier between blood and medical devices has
allowed for modifiable, innovative surface coatings on devices ordinarily plagued by …

The real‐time, continuous monitoring of glucose/lactate, blood gases and electrolytes by
implantable electrochemical sensors holds significant value for critically ill and diabetic …

S-Nitrosoglutathione (GSNO) is a nontoxic nitric oxide (NO)-donating compound that occurs
naturally in the human body. The use of GSNO to deliver exogenous NO for therapeutic and …

Physical incorporation of nitric oxide (NO) releasing materials in biomedical grade polymer
matrices to fabricate antimicrobial coatings and devices is an economically viable process …

Due to biological safety and negligible toxicity, nitric oxide (NO) therapy has gained
increasing interest in the field of cancer therapy during the past few years. However …

Marine mollusk aquaculture has more than doubled over the past twenty years, accounting
for over 15% of total aquaculture production in 2016. Infectious disease is one of the main …

Nitric oxide (NO) plays important roles in both physiology and therapeutics. Nonetheless, the
in-situ monitoring of NO release from most existing donors is challenging, inhibiting …